A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established Atherosclerosis.
Latest Information Update: 20 Feb 2024
At a glance
- Drugs Olmesartan medoxomil (Primary)
- Indications Atherosclerosis
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Inc
- 21 Oct 2006 New trial record.